APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Biopsy Instruments and Kits

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cancer Biopsy Instruments and Kits Industry Growth and Trends Forecast to 2032

Report ID 17442326034 July 2026106 pages

Choose your research edition.

Industry ResearchCancer Biopsy Instruments and Kits Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Biopsy Instruments and Kits Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cancer Biopsy Instruments and Kits Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Biopsy Instruments and Kits Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Biopsy Instruments and Kits Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cancer Biopsy Instruments and Kits market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Biopsy Instruments and Kits is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Biopsy Instruments and Kits include QIAGEN NV, ANGLE plc, Becton, Dickinson and Company, BIOCEPT, INC., Danaher Corporation, Hologic, Inc., Illumina, Inc., Lucence Diagnostics Pte. Ltd. and Myriad Genetics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cancer Biopsy Instruments and Kits market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cancer Biopsy Instruments and Kits market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Biopsy Instruments and Kits market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Biopsy Instruments and Kits.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cancer Biopsy Instruments and Kits market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cancer Biopsy Instruments and Kits Market by Company

QIAGEN NV

ANGLE plc

Becton, Dickinson and Company

BIOCEPT, INC.

Danaher Corporation

Hologic, Inc.

Illumina, Inc.

Lucence Diagnostics Pte. Ltd.

Myriad Genetics

Thermo Fisher Scientific, Inc.

Cancer Biopsy Instruments and Kits Segment by Type

Cancer Biopsy Instruments

Cancer Biopsy Kits

Cancer Biopsy Instruments and Kits Segment by Application

Breast Cancer

Colorectal Cancer

Cervical Cancer

Lung Cancer

Others

Cancer Biopsy Instruments and Kits Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Biopsy Instruments and Kits market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Biopsy Instruments and Kits and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Biopsy Instruments and Kits.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Biopsy Instruments and Kits manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cancer Biopsy Instruments and Kits in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cancer Biopsy Instruments Table 2. Major Company of Cancer Biopsy Kits Table 3. Global Cancer Biopsy Instruments and Kits Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 5. Global Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cancer Biopsy Instruments and Kits Sales Market Share in Value by Type (2021-2026) Table 8. Global Cancer Biopsy Instruments and Kits Price by Type (2021-2026) & (USD/unit) Table 9. Global Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (k units) Table 10. Global Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cancer Biopsy Instruments and Kits Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cancer Biopsy Instruments and Kits Sales Market Share in Value by Type (2027-2032) Table 13. Global Cancer Biopsy Instruments and Kits Price by Type (2027-2032) & (USD/unit) Table 14. North America Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 15. North America Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 17. Europe Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 21. Latin America Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Type (2021-2026) & (US$ Million) Table 24. Cancer Biopsy Instruments and Kits Industry Trends Table 25. Cancer Biopsy Instruments and Kits Industry Drivers Table 26. Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges Table 27. Cancer Biopsy Instruments and Kits Industry Restraints Table 28. Global Cancer Biopsy Instruments and Kits Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cancer Biopsy Instruments and Kits Revenue Market Share by Company (2021-2026) Table 30. Global Cancer Biopsy Instruments and Kits Sales by Company (2021-2026) & (k units) Table 31. Global Cancer Biopsy Instruments and Kits Sales Share by Company (2021-2026) Table 32. Global Cancer Biopsy Instruments and Kits Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Cancer Biopsy Instruments and Kits Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cancer Biopsy Instruments and Kits Major Company Production Sites and Headquarters Table 35. Global Cancer Biopsy Instruments and Kits Company, Product Type & Application Table 36. Global Cancer Biopsy Instruments and Kits Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cancer Biopsy Instruments and Kits by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cancer Biopsy Instruments and Kits Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2026) & (k units) Table 41. Global Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cancer Biopsy Instruments and Kits Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cancer Biopsy Instruments and Kits Sales Market Share in Value by Region (2021-2026) Table 44. Global Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Cancer Biopsy Instruments and Kits Sales by Region (2027-2032) & (k units) Table 46. Global Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cancer Biopsy Instruments and Kits Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cancer Biopsy Instruments and Kits Sales Market Share in Value by Region (2027-2032) Table 49. Global Cancer Biopsy Instruments and Kits Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Cancer Biopsy Instruments and Kits Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 52. Global Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cancer Biopsy Instruments and Kits Sales Market Share in Value by Application (2021-2026) Table 55. Global Cancer Biopsy Instruments and Kits Price by Application (2021-2026) & (USD/unit) Table 56. Global Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (k units) Table 57. Global Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cancer Biopsy Instruments and Kits Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cancer Biopsy Instruments and Kits Sales Market Share in Value by Application (2027-2032) Table 60. Global Cancer Biopsy Instruments and Kits Price by Application (2027-2032) & (USD/unit) Table 61. North America Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 62. North America Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 64. Europe Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 68. Latin America Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Application (2021-2026) & (US$ Million) Table 71. QIAGEN NV Company Information Table 72. QIAGEN NV Business Overview Table 73. QIAGEN NV Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio Table 75. QIAGEN NV Recent Development Table 76. ANGLE plc Company Information Table 77. ANGLE plc Business Overview Table 78. ANGLE plc Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio Table 80. ANGLE plc Recent Development Table 81. Becton, Dickinson and Company Company Information Table 82. Becton, Dickinson and Company Business Overview Table 83. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio Table 85. Becton, Dickinson and Company Recent Development Table 86. BIOCEPT, INC. Company Information Table 87. BIOCEPT, INC. Business Overview Table 88. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio Table 90. BIOCEPT, INC. Recent Development Table 91. Danaher Corporation Company Information Table 92. Danaher Corporation Business Overview Table 93. Danaher Corporation Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio Table 95. Danaher Corporation Recent Development Table 96. Hologic, Inc. Company Information Table 97. Hologic, Inc. Business Overview Table 98. Hologic, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 100. Hologic, Inc. Recent Development Table 101. Illumina, Inc. Company Information Table 102. Illumina, Inc. Business Overview Table 103. Illumina, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 105. Illumina, Inc. Recent Development Table 106. Lucence Diagnostics Pte. Ltd. Company Information Table 107. Lucence Diagnostics Pte. Ltd. Business Overview Table 108. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio Table 110. Lucence Diagnostics Pte. Ltd. Recent Development Table 111. Myriad Genetics Company Information Table 112. Myriad Genetics Business Overview Table 113. Myriad Genetics Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio Table 115. Myriad Genetics Recent Development Table 116. Thermo Fisher Scientific, Inc. Company Information Table 117. Thermo Fisher Scientific, Inc. Business Overview Table 118. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio Table 120. Thermo Fisher Scientific, Inc. Recent Development Table 121. North America Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 123. North America Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2026) Table 124. North America Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Cancer Biopsy Instruments and Kits Sales Market Share Forecast by Country (2027-2032) Table 126. North America Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Cancer Biopsy Instruments and Kits Market Share by Country (2021-2026) Table 129. North America Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Cancer Biopsy Instruments and Kits Market Share Forecast by Country (2027-2032) Table 131. Europe Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 133. Europe Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2026) Table 134. Europe Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Cancer Biopsy Instruments and Kits Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Cancer Biopsy Instruments and Kits Market Share by Country (2021-2026) Table 139. Europe Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Cancer Biopsy Instruments and Kits Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Cancer Biopsy Instruments and Kits Market Share by Country (2021-2026) Table 149. Asia-Pacific Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Cancer Biopsy Instruments and Kits Market Share Forecast by Country (2027-2032) Table 151. Latin America Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 153. Latin America Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2026) Table 154. Latin America Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Cancer Biopsy Instruments and Kits Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Cancer Biopsy Instruments and Kits Market Share by Country (2021-2026) Table 159. Latin America Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Cancer Biopsy Instruments and Kits Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Cancer Biopsy Instruments and Kits Market Share by Country (2021-2026) Table 169. Middle East and Africa Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Cancer Biopsy Instruments and Kits Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Cancer Biopsy Instruments and Kits Distributors List Table 174. Cancer Biopsy Instruments and Kits Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Cancer Biopsy Instruments and Kits Image Figure 2. Global Cancer Biopsy Instruments and Kits Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Biopsy Instruments and Kits Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Biopsy Instruments and Kits Sales (2021-2032) & (k units) Figure 5. Cancer Biopsy Instruments Image Figure 6. Global Cancer Biopsy Instruments Sales YoY Growth (2021-2032) & (k units) Figure 7. Cancer Biopsy Kits Image Figure 8. Global Cancer Biopsy Kits Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Cancer Biopsy Instruments and Kits Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cancer Biopsy Instruments and Kits Market Share by Type 2025 VS 2032 Figure 11. North America Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Type in 2025 Figure 12. North America Cancer Biopsy Instruments and Kits Sales Market Share in Value by Type in 2025 Figure 13. Europe Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cancer Biopsy Instruments and Kits Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cancer Biopsy Instruments and Kits Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cancer Biopsy Instruments and Kits Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Breast Cancer Image Figure 24. Global Breast Cancer Sales YoY Growth (2021-2032) & (k units) Figure 25. Colorectal Cancer Image Figure 26. Global Colorectal Cancer Sales YoY Growth (2021-2032) & (k units) Figure 27. Cervical Cancer Image Figure 28. Global Cervical Cancer Sales YoY Growth (2021-2032) & (k units) Figure 29. Lung Cancer Image Figure 30. Global Lung Cancer Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Cancer Biopsy Instruments and Kits Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Cancer Biopsy Instruments and Kits Market Share by Application 2025 VS 2032 Figure 35. North America Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Application in 2025 Figure 36. North America Cancer Biopsy Instruments and Kits Sales Market Share in Value by Application in 2025 Figure 37. Europe Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Application in 2025 Figure 38. Europe Cancer Biopsy Instruments and Kits Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Market Share in Value by Application in 2025 Figure 41. Latin America Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Cancer Biopsy Instruments and Kits Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Market Share in Value by Application in 2025 Figure 45. North America Cancer Biopsy Instruments and Kits Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Cancer Biopsy Instruments and Kits Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Cancer Biopsy Instruments and Kits Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cancer Biopsy Instruments and Kits Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Cancer Biopsy Instruments and Kits Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Cancer Biopsy Instruments and Kits Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Cancer Biopsy Instruments and Kits Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Cancer Biopsy Instruments and Kits Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cancer Biopsy Instruments and Kits Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Cancer Biopsy Instruments and Kits Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Cancer Biopsy Instruments and Kits Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Cancer Biopsy Instruments and Kits Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Cancer Biopsy Instruments and Kits Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Cancer Biopsy Instruments and Kits Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cancer Biopsy Instruments and Kits Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Cancer Biopsy Instruments and Kits Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Cancer Biopsy Instruments
  • Cancer Biopsy Kits
Applications
  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancer
  • Lung Cancer
  • Others
Companies covered
  • QIAGEN NV
  • ANGLE plc
  • Becton, Dickinson and Company
  • BIOCEPT, INC.
  • Danaher Corporation
  • Hologic, Inc.
  • Illumina, Inc.
  • Lucence Diagnostics Pte. Ltd.
  • Myriad Genetics
  • Thermo Fisher Scientific, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cancer Biopsy Instruments and Kits Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cancer Biopsy Instruments and Kits Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cancer Biopsy Instruments and Kits Market by Type
  6. 1.3.1 Cancer Biopsy Instruments
  7. 1.3.2 Cancer Biopsy Kits
  8. 1.4 Global Cancer Biopsy Instruments and Kits Market Size by Type
  9. 1.4.1 Global Cancer Biopsy Instruments and Kits Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cancer Biopsy Instruments and Kits Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cancer Biopsy Instruments and Kits Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cancer Biopsy Instruments and Kits Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cancer Biopsy Instruments and Kits Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cancer Biopsy Instruments and Kits Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cancer Biopsy Instruments and Kits Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cancer Biopsy Instruments and Kits Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cancer Biopsy Instruments and Kits Industry Trends
  2. 2.2 Cancer Biopsy Instruments and Kits Industry Drivers
  3. 2.3 Cancer Biopsy Instruments and Kits Industry Opportunities and Challenges
  4. 2.4 Cancer Biopsy Instruments and Kits Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cancer Biopsy Instruments and Kits Revenue (2021-2026)
  2. 3.2 Global Top Players by Cancer Biopsy Instruments and Kits Sales (2021-2026)
  3. 3.3 Global Top Players by Cancer Biopsy Instruments and Kits Price (2021-2026)
  4. 3.4 Global Cancer Biopsy Instruments and Kits Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Biopsy Instruments and Kits Major Company Production Sites & Headquarters
  6. 3.6 Global Cancer Biopsy Instruments and Kits Company, Product Type & Application
  7. 3.7 Global Cancer Biopsy Instruments and Kits Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Biopsy Instruments and Kits Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Biopsy Instruments and Kits Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Biopsy Instruments and Kits Tier 1, Tier 2, and Tier 3
4 Cancer Biopsy Instruments and Kits Regional Status and Outlook
  1. 4.1 Global Cancer Biopsy Instruments and Kits Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cancer Biopsy Instruments and Kits Historic Market Size by Region
  3. 4.2.1 Global Cancer Biopsy Instruments and Kits Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cancer Biopsy Instruments and Kits Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cancer Biopsy Instruments and Kits Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cancer Biopsy Instruments and Kits Forecasted Market Size by Region
  7. 4.3.1 Global Cancer Biopsy Instruments and Kits Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cancer Biopsy Instruments and Kits Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cancer Biopsy Instruments and Kits Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cancer Biopsy Instruments and Kits by Application
  1. 5.1 Cancer Biopsy Instruments and Kits Market by Application
  2. 5.1.1 Breast Cancer
  3. 5.1.2 Colorectal Cancer
  4. 5.1.3 Cervical Cancer
  5. 5.1.4 Lung Cancer
  6. 5.1.5 Others
  7. 5.2 Global Cancer Biopsy Instruments and Kits Market Size by Application
  8. 5.2.1 Global Cancer Biopsy Instruments and Kits Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Cancer Biopsy Instruments and Kits Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Cancer Biopsy Instruments and Kits Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Cancer Biopsy Instruments and Kits Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Cancer Biopsy Instruments and Kits Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Cancer Biopsy Instruments and Kits Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Cancer Biopsy Instruments and Kits Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Cancer Biopsy Instruments and Kits Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 QIAGEN NV
  2. 6.1.1 QIAGEN NV Company Information
  3. 6.1.2 QIAGEN NV Business Overview
  4. 6.1.3 QIAGEN NV Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 QIAGEN NV Cancer Biopsy Instruments and Kits Product Portfolio
  6. 6.1.5 QIAGEN NV Recent Developments
  7. 6.2 ANGLE plc
  8. 6.2.1 ANGLE plc Company Information
  9. 6.2.2 ANGLE plc Business Overview
  10. 6.2.3 ANGLE plc Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ANGLE plc Cancer Biopsy Instruments and Kits Product Portfolio
  12. 6.2.5 ANGLE plc Recent Developments
  13. 6.3 Becton, Dickinson and Company
  14. 6.3.1 Becton, Dickinson and Company Company Information
  15. 6.3.2 Becton, Dickinson and Company Business Overview
  16. 6.3.3 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Becton, Dickinson and Company Cancer Biopsy Instruments and Kits Product Portfolio
  18. 6.3.5 Becton, Dickinson and Company Recent Developments
  19. 6.4 BIOCEPT, INC.
  20. 6.4.1 BIOCEPT, INC. Company Information
  21. 6.4.2 BIOCEPT, INC. Business Overview
  22. 6.4.3 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BIOCEPT, INC. Cancer Biopsy Instruments and Kits Product Portfolio
  24. 6.4.5 BIOCEPT, INC. Recent Developments
  25. 6.5 Danaher Corporation
  26. 6.5.1 Danaher Corporation Company Information
  27. 6.5.2 Danaher Corporation Business Overview
  28. 6.5.3 Danaher Corporation Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Danaher Corporation Cancer Biopsy Instruments and Kits Product Portfolio
  30. 6.5.5 Danaher Corporation Recent Developments
  31. 6.6 Hologic, Inc.
  32. 6.6.1 Hologic, Inc. Company Information
  33. 6.6.2 Hologic, Inc. Business Overview
  34. 6.6.3 Hologic, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hologic, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  36. 6.6.5 Hologic, Inc. Recent Developments
  37. 6.7 Illumina, Inc.
  38. 6.7.1 Illumina, Inc. Company Information
  39. 6.7.2 Illumina, Inc. Business Overview
  40. 6.7.3 Illumina, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Illumina, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  42. 6.7.5 Illumina, Inc. Recent Developments
  43. 6.8 Lucence Diagnostics Pte. Ltd.
  44. 6.8.1 Lucence Diagnostics Pte. Ltd. Company Information
  45. 6.8.2 Lucence Diagnostics Pte. Ltd. Business Overview
  46. 6.8.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Instruments and Kits Product Portfolio
  48. 6.8.5 Lucence Diagnostics Pte. Ltd. Recent Developments
  49. 6.9 Myriad Genetics
  50. 6.9.1 Myriad Genetics Company Information
  51. 6.9.2 Myriad Genetics Business Overview
  52. 6.9.3 Myriad Genetics Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Myriad Genetics Cancer Biopsy Instruments and Kits Product Portfolio
  54. 6.9.5 Myriad Genetics Recent Developments
  55. 6.10 Thermo Fisher Scientific, Inc.
  56. 6.10.1 Thermo Fisher Scientific, Inc. Company Information
  57. 6.10.2 Thermo Fisher Scientific, Inc. Business Overview
  58. 6.10.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Instruments and Kits Product Portfolio
  60. 6.10.5 Thermo Fisher Scientific, Inc. Recent Developments
7 North America by Country
  1. 7.1 North America Cancer Biopsy Instruments and Kits Sales by Country
  2. 7.1.1 North America Cancer Biopsy Instruments and Kits Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cancer Biopsy Instruments and Kits Sales by Country (2021-2026)
  4. 7.1.3 North America Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cancer Biopsy Instruments and Kits Market Size by Country
  6. 7.2.1 North America Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026)
  8. 7.2.3 North America Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cancer Biopsy Instruments and Kits Sales by Country
  2. 8.1.1 Europe Cancer Biopsy Instruments and Kits Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cancer Biopsy Instruments and Kits Sales by Country (2021-2026)
  4. 8.1.3 Europe Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cancer Biopsy Instruments and Kits Market Size by Country
  6. 8.2.1 Europe Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Country
  2. 9.1.1 Asia-Pacific Cancer Biopsy Instruments and Kits Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cancer Biopsy Instruments and Kits Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cancer Biopsy Instruments and Kits Market Size by Country
  6. 9.2.1 Asia-Pacific Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cancer Biopsy Instruments and Kits Sales by Country
  2. 10.1.1 South America Cancer Biopsy Instruments and Kits Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cancer Biopsy Instruments and Kits Sales by Country (2021-2026)
  4. 10.1.3 South America Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cancer Biopsy Instruments and Kits Market Size by Country
  6. 10.2.1 South America Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026)
  8. 10.2.3 South America Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country
  2. 11.1.1 Middle East and Africa Cancer Biopsy Instruments and Kits Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cancer Biopsy Instruments and Kits Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cancer Biopsy Instruments and Kits Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cancer Biopsy Instruments and Kits Market Size by Country
  6. 11.2.1 Middle East and Africa Cancer Biopsy Instruments and Kits Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cancer Biopsy Instruments and Kits Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cancer Biopsy Instruments and Kits Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cancer Biopsy Instruments and Kits Value Chain Analysis
  2. 12.1.1 Cancer Biopsy Instruments and Kits Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cancer Biopsy Instruments and Kits Production Mode & Process
  7. 12.2 Cancer Biopsy Instruments and Kits Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cancer Biopsy Instruments and Kits Distributors
  10. 12.2.3 Cancer Biopsy Instruments and Kits Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst